Our Proud History

Xenoscience has been a clinical research site since 2001. Founded by Stephen Flitman, MD as an Alzheimer specialty center, Xenoscience expanded into general neurology and advanced pain management. Joshua Tobin, MD joined in 2006 and added expertise in Migraine and atypical headache. We have been involved in over 200 clinical trials and have contributed to the approvals of many drugs.

These are the treatments which Xenoscience has helped to develop over the years which were eventually approved by the US Food and Drug Administration (FDA). Most have also been approved by the EU equivalent agency, European Medicines Agency.

Treatments for Alzheimer's Disease

  • Aricept
  • Axona
  • Exelon
  • Exelon Patch
  • Razadyne
  • Razadyne ER

Treatments for Epilepsy

  • Aptiom
  • Briviact
  • Fycompa
  • Oxtellar XR
  • Vimpat

Treatments for Fibromyalgia

  • Cymbalta
  • Savella

Treatments for Multiple Sclerosis

  • Aubagio
  • Gilenya
  • Plegridy
  • Tecfidera

Treatments for Neuropathic Pain

  • Lyrica for Diabetic Neuropathy Pain
  • Qutenza for HIV Neuropathy Pain

Treatments for Parkinson's Disease

  • Stalevo for improved motor function






A sobering thought: For every drug that is successfully brought to the US market, many more (sometimes as many as hundreds more) have failed in clinical trials.

Print/export
QR Code
QR Code success (generated for current page)